GWM
Geneos Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,494
| Closed | -$52K | – | 3123 |
|
|
2025
Q1 | $52K | Buy |
+2,494
| New | +$52K | ﹤0.01% | 1903 |
|
|
2024
Q4 | – | Sell |
-35,150
| Closed | -$689K | – | 2890 |
|
|
2024
Q3 | $689K | Buy |
35,150
+1,600
| +5% | +$31.4K | 0.03% | 482 |
|
|
2024
Q2 | $658K | Sell |
33,550
-10,200
| -23% | -$200K | 0.03% | 434 |
|
|
2024
Q1 | $788K | Buy |
43,750
+2,364
| +6% | +$42.6K | 0.04% | 395 |
|
|
2023
Q4 | $701K | Buy |
41,386
+3,249
| +9% | +$55.1K | 0.03% | 396 |
|
|
2023
Q3 | $757K | Buy |
38,137
+21,187
| +125% | +$421K | 0.04% | 371 |
|
|
2023
Q2 | $318K | Sell |
16,950
-2,052
| -11% | -$38.5K | 0.02% | 573 |
|
|
2023
Q1 | $388K | Buy |
19,002
+15,983
| +529% | +$326K | 0.02% | 494 |
|
|
2022
Q4 | $64K | Buy |
+3,019
| New | +$64K | ﹤0.01% | 959 |
|